Associate Professor, Radiation Oncology, UCSD School of Medicine
Radiation Oncology
Dr. Loren K. Mell, MD
|
|
Give Review
Loren Mell is an expert in the field of Radiation Oncology. He went to medical school at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. Loren K. Mell is a published doctor and has 71 publications published. The lastest was: 'Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer.' He is registered with Medicare and accepts Medicare payments.
Publications
- Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy.
- Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events.
- Dose-Dependent Cortical Thinning After Partial Brain Irradiation in High-Grade Glioma.
- Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study.
- Variation in the Cost of Radiation Therapy Among Medicare Patients With Cancer.
- Survival in unresectable sinonasal undifferentiated carcinoma treated with concurrent intra-arterial cisplatin and radiation.
- Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck.
- Proton density water fraction as a biomarker of bone marrow cellularity: Validation in ex vivo spine specimens.
- Age disparity in palliative radiation therapy among patients with advanced Cancer.
- Validated Competing Event Model for the Stage I-II Endometrial Cancer Population.
- Fat Composition Changes in Bone Marrow During Chemotherapy and Radiation Therapy.
- Palliative Radiation Before Hospice: The Long and the Short of It.
- On Lumping, Splitting, and the Nosology of Clinical Trial Populations and End Points.
- Automatic treatment plan re-optimization for adaptive radiotherapy guided with the initial plan DVHs.
- Cause-Specific Effects of Radiotherapy and Lymphadenectomy in Stage I-II Endometrial Cancer: A Population-Based Study.
- Race and competing mortality in advanced head and neck Cancer.
- Patterns of Care in Palliative Radiotherapy: A Population-Based Study.
- Feasibility study on dosimetry verification of volumetric- modulated arc therapy-based total marrow irradiation.
- A contour-guided deformable image registration algorithm for adaptive radiotherapy.
- Outcomes for patients with cervical Cancer treated with extended-field intensity-modulated radiation therapy and concurrent cisplatin.
- The effect of treatment time in locally advanced cervical Cancer in the era of concurrent chemoradiotherapy.
- Intensity modulated radiation therapy for gynecologic malignancies: a testable hypothesis.
- Competing event risk stratification may improve the design and efficiency of clinical trials: Secondary analysis of SWOG 8794.
- Prospective Study of Functional Bone Marrow-Sparing Intensity Modulated Radiation Therapy With Concurrent Chemotherapy for Pelvic Malignancies.
- Reporting of Cause-Specific Treatment Effects in Cancer Clinical Trials with Competing Risks: A Systematic Review.
- Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical Cancer patients undergoing intensity modulated radiation therapy and con...
- Clinical Practice Patterns of Lung Stereotactic Body Radiation Therapy in the United States: A Secondary Analysis.
- Population-Based Study of Competing Mortality in Head and Neck Cancer.
- A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy.
- Daily online cone beam computed tomography to assess interfractional motion in patients with intact cervical Cancer.
- A survey of stereotactic body radiotherapy use in the United States.
- Normal tissue complication probability modeling of acute hematologic toxicity in cervical Cancer patients treated with chemoradiotherapy.
- Outcomes in black patients with early breast Cancer treated with breast conservation therapy.
- Predictors of competing mortality in early breast Cancer.
- Impact of bone marrow radiation dose on acute hematologic toxicity in cervical Cancer: principal component analysis on high dimensional data.
- Pitfalls of using composite primary end points in the presence of competing risks.
- A survey of image-guided radiation therapy use in the United States.
- Clinical Outcomes of Intensity-Modulated Pelvic Radiation Therapy for Carcinoma of the Cervix.
- Dosimetric comparison study between intensity modulated radiation therapy and three-dimensional conformal proton therapy for pelvic bone marrow sparing in the treatmen...
- Predictors of competing mortality in advanced head and neck Cancer.
- Utilization of advanced imaging technologies for target delineation in radiation oncology.
- Magnetic resonance imaging identifies multifocal and multicentric disease in breast Cancer patients who are eligible for partial breast irradiation.
- Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck Cancer.
- Dosimetric comparison of bone marrow-sparing intensity-modulated radiotherapy versus conventional techniques for treatment of cervical Cancer.
- Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical Cancer.
- Intensity-modulated radiation therapy in gynecologic Cancers: growing support, growing acceptance.
- Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal Cancer patients treated with concurrent chemotherapy and intensity-modulat...
- More on cetuximab in head and neck Cancer.
- Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal Cancer patients: a multicenter experience.
- Effect of amifostine on response rates in locally advanced non-small-cell lung Cancer patients treated on randomized controlled trials: a meta-analysis.
- Dosimetric predictors of acute hematologic toxicity in cervical Cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy.
- Intensity-modulated radiation therapy in gynecologic malignancies: current status and future directions.
- A dosimetric analysis of intensity-modulated radiation therapy (IMRT) as an alternative to adjuvant high-dose-rate (HDR) brachytherapy in early endometrial Cancer pati...
- Radiation therapy in the elderly.
- Intensity-modulated radiation therapy use in the U.S., 2004.
- Association between streptococcal infection and obsessive-compulsive disorder, Tourette's syndrome, and tic disorder.
- Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical Cancer patients.
- Prognostic significance of E-cadherin protein expression in pathological stage I-III endometrial Cancer.
- Intensity-modulated radiotherapy and the Internet.
- Concern with "Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial Cancer?".
- Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy.
- A survey of intensity-modulated radiation therapy use in the United States.
- Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix Cancer.
- How does TPF improve survival over PF?
- A multi-institutional acute gastrointestinal toxicity analysis of anal Cancer patients treated with concurrent intensity-modulated radiation therapy (IMRT) and chemoth...
- Compliance with national immunization guidelines for children younger than 2 years, 1996-1999.
- A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy.
- Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine.
- Polio extraimmunization in children younger than 2 years after changes in immunization recommendations.
- Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer.
Schools
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Conditions Treated
- Vulvar Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
University of Chicago -
University of Chicago Pritzker School of Medicine
Hospital
-
UC San Diego Health
Drug Facts
| NPI NUMBER | 1316119704 | |
| NPPES Provider LastName | MELL | |
| NPPES Provider FirstName | LOREN | |
| NPPES Provider ZIPCode | 92093 | |
| NPPES Provider State | CA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 40.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316119704 |
| Last Name Of The Provider | MELL |
| First Name Of The Provider | LOREN |
| View All |
Similar Doctors
|
|
Dr. Parag R. Sanghvi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunil J. Advani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert W. Aschenbrenner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ruth H. Grobstein, MD |
|
|
Dr. Ray Lin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin T. Murphy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James D. Murphy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chien P. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nhat-Long L. Pham, MD |
|
|
Dr. Ajay P. Sandhu, MD |
|
|
Dr. Catheryn M. Yashar, MD
This Doctor is OpenDoctor Recommended.
|